newsfilter
← Latest News
Business Wire·

Immunome to Present at Upcoming Investor Conferences

Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that members of Immunome's management will participate in the